News round-up for 27 – 31 October by Bruno Quinney, Content Team at DDW.
Women’s health is top of this week’s agenda, as Bayer paves the way for a new approach to treat hot flashes due to menopause. Elsewhere, an anti-obesity medication has health benefits beyond weight loss and Alector has discontinued its dementia drug.
The top stories:
Bayer’s new approach to hot flashes receives FDA approval
The US Food and Drug Administration (FDA) has approved Lynkuet (elinzanetant) 60mg…
